Dr. Jane Buchan added another feather to her cap on Wednesday by joining the Immix Biopharma board of directors.
Buchan is well known for her role in co-founding the fund of hedge funds PAAMCO in 2000. The firm grew to $32 billion in AUM during her 18 years at the helm. Her trading group spun off from PAAMCO and began operating independently as Martlet Asset Management in January 2019.
"ImmixBio is a transformative company with exceptional leadership that is working to build a world-class biopharmaceutical platform," Dr. Buchan said. "I am looking . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.